Trials / Unknown
UnknownNCT05273333
Effect of Ultra-gyn® on Vulvovaginal Candidiasis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Biocodex · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this post-market clinical follow up study is to confirm the performance and the safety of Ultra-gyn® (when used in accordance with its approved labelling)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ultra-gyn® | Ultra-gyn® ovule intravaginal application, every evening before bedtime for a 10 days period. |
Timeline
- Start date
- 2022-02-23
- Primary completion
- 2022-07-01
- Completion
- 2022-12-01
- First posted
- 2022-03-10
- Last updated
- 2022-03-10
Locations
1 site across 1 country: Mauritius
Source: ClinicalTrials.gov record NCT05273333. Inclusion in this directory is not an endorsement.